Abstract
Objective: A new series 2-phenyl-3-(substituted benzo[d] thiazol-2-ylamino)-quinazoline-4(3H)-one was prepared by the fusion method by reacting 2-phenyl benzoxazine with 2-hydrazino benzothiazole and it was evaluated for their antimicrobial activity against gram positive, gram negative bacteria and fungi.Methods: Titled compounds were synthesized by fusion reactions. These compounds were evaluated by in vitro antibacterial and antifungal activity using the minimum inhibitory concentration and zone of inhibition methods. The synthesized compounds were characterized with the help of infrared, NMR and mass spectral studies. The benzothiazole moiety and the quinazoline ring have previously shown DNA gyrase inhibition and target related antibacterial activity. Thus, molecular docking studies of synthesized compounds were carried out (PDB: 3G75) to study the possible interaction of compounds with the target. The batch grid docking was performed to determine the probable.Results: These compounds showed significant activity against gram positive and gram negative bacteria as well against the fungi. The compound A5 was found to be active against B. subtilis, P aeruginosa and C. albican at 12.5 µg/ml MIC. The compound A3 was found to be active against all microbial strains selected at 25 and 12.5 µg/ml MIC.Conclusion: Though the relationship between the activities shown by these compounds in, the antimicrobial study is still to be established, the docking studies conducted found to be consistent with antimicrobial results. Thus the results indicate that the designed structure can be a potential lead as an antimicrobial agent.
Highlights
There has been a continual encounter between human and the multitude of microorganism that cause infection and disease
The compound A-5 with nitro substitution at the 6th position of benzothiazole was found to hold potential antibacterial and antifungal activity against B. subtilis, P. aeruginosa and C. albicans. The compound A5 was found to be active against B. subtilis, P aeruginosa and C. albican at 12.5 μg/ml MIC
The number of substituted benzothiazoles fused with quinazoline moieties was synthesized and screened for antibacterial and antifungal activity
Summary
There has been a continual encounter between human and the multitude of microorganism that cause infection and disease. The number of cases of multidrug-resistant bacterial infections is increasing day by day. This situation requires the design of novel antimicrobial agents acting on novel targets. Benzothiazole derivatives show numerous biological activities such as antimicrobial [1], anticancer [2], antileishmanial [3], anti-diabetic and antifungal [4] activities. In recent years’ heterocyclic compounds and derivatives have attracted strong interest due to their biological and pharmacological properties. Substituted quinazoline-4-one have been shown to possess antibacterial, antifungal and antimicrobial activity [5,6,7]. It is revealed from the literature that benzothiazole, as well as quinazolin-4-one derivatives, hold diverse pharmacological activity
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Pharmacy and Pharmaceutical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
